Latest Breaking News On - Durable subretinal - Page 1 : comparemela.com

/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced that three presentations on RGX-314 will be presented at the Angiogenesis, Exudation, and.

United statesPetera campochiaroDana cormackCharlesc wykoffChris brinzeyJohn hopkins school of medicineMolecular laboratoryTechnology platformCorporate communicationsTechnology platform licenseesRetina researchSubretinal deliveryRetina consultantsLong term follow upDurable subretinalWills eye hospital